pcDNA3-EFNB2-RBD-Fc (D62Q-Q130L-V167L)
(Plasmid
#200980)
-
PurposeMammalian expression plasmid for soluble EFNB2 (D62Q-Q130L-V167L specificity mutant) fused to IgG1 Fc
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 200980 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3
- Backbone size w/o insert (bp) 5332
- Total vector size (bp) 6526
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameEFNB2
-
Alt nameEphrinB2
-
SpeciesH. sapiens (human)
-
Insert Size (bp)1194
-
MutationSoluble Receptor-Binding Domain; D62Q-Q130L-V167L mutation for increased specificity to henipaviral G proteins
-
GenBank IDNP_004084.1
-
Entrez GeneEFNB2 (a.k.a. EPLG5, HTKL, Htk-L, LERK5, ephrin-B2)
- Promoter CMV
-
Tag
/ Fusion Protein
- IgG1 Fc (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMV forward
- 3′ sequencing primer BGH reverse (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2023.04.26.538420 for bioRxiv preprint.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3-EFNB2-RBD-Fc (D62Q-Q130L-V167L) was a gift from Erik Procko (Addgene plasmid # 200980 ; http://n2t.net/addgene:200980 ; RRID:Addgene_200980) -
For your References section:
Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins. Narayanan KK, Amaya M, Tsang N, Yin R, Jays A, Broder CC, Shukla D, Procko E. J Virol. 2023 Nov 30;97(11):e0062123. doi: 10.1128/jvi.00621-23. Epub 2023 Oct 16. 10.1128/jvi.00621-23 PubMed 37931130